Literature DB >> 24762144

Torsional properties of distal femoral cortical defects.

Derek F Amanatullah, Joel C Williams, David P Fyhrie, Robert M Tamurian.   

Abstract

The optimal management of pathologic long bone lesions remains a challenge in orthopedic surgery. The goal of the current study was to investigate the effect of defect depth on the torsional properties of the distal femur. A laterally placed distal metaphyseal cylindrical defect was milled in the cortex of the distal femur in 20 composite models. The proximal extent of the defects was constant. By decreasing the radius of the cylinder that intersected this predefined cord, 4 different radii defining 4 different depths of resection of the distal femur were created for testing: 17%, 33%, 50%, and 67% cortical defects, when normalized to the width of the femur at the level of resection. Each femur was mounted into a hydraulic axial/torsion materials testing machine and each specimen underwent torsional stiffness testing and torsional failure in external rotation. The specimens with less than a 33% cortical loss consistently demonstrated a superiorly oriented spiral fracture pattern, while the specimens with greater than a 50% cortical loss consistently demonstrated an inferiorly oriented transverse fracture pattern. The cortical defects were all statistically (P<.05) less stiff in torsion as the defect grew larger. There was a strong linear correlation between the mean torsional stiffness and cortical defect size (r(2)=0.977). This observation is supported by finite element analysis. The amount of femur remaining is crucial to stability. This biomechanical analysis predicts a critical loss of torsional integrity when a cortical defect approaches 50% of the width of the femur. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh:

Year:  2014        PMID: 24762144     DOI: 10.3928/01477447-20140225-51

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  7 in total

1.  Impact of Femoral Neck Cortical Bone Defect Induced by Core Decompression on Postoperative Stability: A Finite Element Analysis.

Authors:  Daizhu Yuan; Zhanyu Wu; Siwei Luo; Qiang Zou; Zihao Zou; Chuan Ye
Journal:  Biomed Res Int       Date:  2022-05-20       Impact factor: 3.246

2.  Risk factors of fracture following curettage for bone giant cell tumors of the extremities.

Authors:  Shinji Tsukamoto; Andreas F Mavrogenis; Manabu Akahane; Kanya Honoki; Akira Kido; Yasuhito Tanaka; Davide Maria Donati; Costantino Errani
Journal:  BMC Musculoskelet Disord       Date:  2022-05-19       Impact factor: 2.562

3.  Combining mesenchymal stem cell sheets with platelet-rich plasma gel/calcium phosphate particles: a novel strategy to promote bone regeneration.

Authors:  Yiying Qi; Lie Niu; Tengfei Zhao; Zhongli Shi; Tuoyu Di; Gang Feng; Junhua Li; Zhongming Huang
Journal:  Stem Cell Res Ther       Date:  2015-12-21       Impact factor: 6.832

4.  The insufficiencies of risk analysis of impending pathological fractures in patients with femoral metastases: A literature review.

Authors:  Emir Benca; Janina M Patsch; Winfried Mayr; Dieter H Pahr; Reinhard Windhager
Journal:  Bone Rep       Date:  2016-03-02

5.  QCT-based finite element prediction of pathologic fractures in proximal femora with metastatic lesions.

Authors:  Emir Benca; Alexander Synek; Morteza Amini; Franz Kainberger; Lena Hirtler; Reinhard Windhager; Winfried Mayr; Dieter H Pahr
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

6.  Post-operative fracture risk assessment following tumor curettage in the distal femur: a hybrid in vitro and in silico biomechanical approach.

Authors:  Azadeh Ghouchani; Gholamreza Rouhi; Mohammad Hosein Ebrahimzadeh
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

7.  Application of allograft and absorbable screws in the reconstruction of a massive bone defect following resection of giant osteochondroma: A retrospective study.

Authors:  Zhihao Ma; Qiang Yang; Xinyu Liu; Zhenfeng Li
Journal:  Front Surg       Date:  2022-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.